MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Behavioral abnormalities"

  • 2017 International Congress

    Co-speech gestures in Parkinson’s disease (PD)

    M. Bacigalupe (La Plata, Argentina)

    Objective: We develop an analytical description of co-speech gesture production in PD patients. Background: Communication and expressive behavior problems are frequent in PD patients (Duncan…
  • 2017 International Congress

    VIT-D and Tics Movement Disorder

    N. GEMAWAT (MUMBAI, India)

    Objective: Tics  is  common childhood movement disorder,  with classified variants , typically begin at around 4-5 years of age but often  present  lator at about…
  • 2017 International Congress

    Noladin ether attenuates MPTP -induced motor deficit by abrogating pro-inflammatory cytokines and striatal neurochemical alterations in rats

    R. Deshmukh, S. Singh (Moga, India)

    Objective: The present study was designed to investigate the therapeutic potential of noladin ether- a putative endocannabinoid against MPTP-induced behavioral, biochemical and neurochemical alterations in…
  • 2017 International Congress

    Hypometabolism in Orbitofrontal and Perirhinal Cortex is Associated with Impulse Control Disorder in Parkinson´s Disease

    I. Navalpotro-Gomez, A. Botas-Peñín, F. Molinet-Dronda, C. Gasca-Salas, M. Carmona-Abellán, H. Jiménez-Urbieta, M. Delgado-Alvarado, A. Quiroga-Varela, B. Gago, M.C. Rodríguez-Oroz (San Sebastian, Spain)

    Objective: (i)To elucidate the metabolic correlates sub-serving the clinical expression of ICD in PD and (ii) to evaluate the association between the glucose metabolism and…
  • 2017 International Congress

    F-18-DOPA-PET predicts impulsive behavior under dopaminergic therapy in Parkinson patients

    J. Hammes, M. Tittgemeyer, C. Eggers, A. Drzezga, T. van Eimeren (Cologne, Germany)

    Objective: The aim of this study is to investigate the influence of the intensity of dopaminergic projections to the ventral striatum (VS) measured with F-18-DOPA-PET…
  • 2017 International Congress

    Neural Correlates Underlying Reward Processing and Decision-Making in Impulse Control Disorder in Parkinson´s Disease

    I. Navalpotro-Gomez, P. Paz-Alonso, P. Boddy, M. Delgado-Alvarado, H. Jimenez-Urbieta, A. Quiroga-Varela, B. Gago, M. Carreiras, M.C. Rodriguez-Oroz (San Sebastian, Spain)

    Objective: To investigate the functional neural basis of decision-making in PD-ICD subjects using a modified version of the Iowa Gambling Task (IGT) paradigm. Background: Impulse…
  • 2017 International Congress

    The brain plasticity for controlling reach-to-grasp functions of Parkinson’s disease

    J. Tretriluxana, S. Tretriluxana, J. Thanakamchokchai, A. Nanbancha, A. Pisarnpong (Nakhon Pathom, Thailand)

    Objective: To investigate the brain plasticity for controlling the dominant and non-dominant hand muscles and reach-to-grasp (RTG) functions in Parkinson’s disease (PD). Background: Previous studies…
  • 2016 International Congress

    Neuropsychological correlates of impulse control disorders and punding in Parkinson´ s disease

    G. Santangelo, F. Falco, M. Vicidomini, R. Allocca, P. Barone, C. Vitale (Caserta, Italy)

    Objective: To investigate the relationship between cognitive deficits, Impulse Control Disorders (ICDs) and Punding in Parkinson's disease (PD). Background: The neuropsychological correlates of ICDs and…
  • 2016 International Congress

    Technology use and impulse control disorders (ICDs) in patients with Parkinson’s disease (PD)

    E.A. Byrd, C.M. Tanner, C.A. Racine, N.B. Galifianakis (San Francisco, CA, USA)

    Objective: To ascertain the prevalence of problematic technology use (Technology-related ICDs, Tech-ICDs) in patients with PD. Background: ICDs are a known complication of PD drugs…
  • 2016 International Congress

    Volition and action control in Parkinson’s disease patients with impulsive-compulsive behaviour disorders

    L. Ricciardi, P. Haggard, L. de Boer, C. Sorbera, M.P. Stenner, F. Morgante, M.J. Edwards (London, United Kingdom)

    Objective: We aimed to explore different aspects of action control, assessing reward-related behaviour, inhibition (externally and internally triggered) and sense of agency in Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley